These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29066368)

  • 1. Investigating the efficacy of a combination Aβ-targeted treatment in a mouse model of Alzheimer's disease.
    Liu M; Jevtic S; Markham-Coultes K; Ellens NPK; O'Reilly MA; Hynynen K; Aubert I; McLaurin J
    Brain Res; 2018 Jan; 1678():138-145. PubMed ID: 29066368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo uptake of β-amyloid by non-plaque associated microglia.
    Hawkes CA; Deng L; Fenili D; Nitz M; McLaurin J
    Curr Alzheimer Res; 2012 Oct; 9(8):890-901. PubMed ID: 22272621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-beta plaque load in the TgCRND8 mouse model of Alzheimer's disease.
    Jordão JF; Ayala-Grosso CA; Markham K; Huang Y; Chopra R; McLaurin J; Hynynen K; Aubert I
    PLoS One; 2010 May; 5(5):e10549. PubMed ID: 20485502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Neurotrophic Support and Amyloid-Targeted Combined Therapy on Adult Hippocampal Neurogenesis in a Transgenic Model of Alzheimer's Disease.
    Morrone CD; Thomason LA; Brown ME; Aubert I; McLaurin J
    PLoS One; 2016; 11(10):e0165393. PubMed ID: 27768761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
    Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
    J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-β plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound.
    Jordão JF; Thévenot E; Markham-Coultes K; Scarcelli T; Weng YQ; Xhima K; O'Reilly M; Huang Y; McLaurin J; Hynynen K; Aubert I
    Exp Neurol; 2013 Oct; 248():16-29. PubMed ID: 23707300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule beta-amyloid inhibitors that stabilize protofibrillar structures in vitro improve cognition and pathology in a mouse model of Alzheimer's disease.
    Hawkes CA; Deng LH; Shaw JE; Nitz M; McLaurin J
    Eur J Neurosci; 2010 Jan; 31(2):203-13. PubMed ID: 20074226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
    Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
    Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of scyllo-inositol as a therapeutic treatment of AD-like pathology.
    Fenili D; Brown M; Rappaport R; McLaurin J
    J Mol Med (Berl); 2007 Jun; 85(6):603-11. PubMed ID: 17279347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy in a transgenic model of Alzheimer's disease.
    Aytan N; Choi JK; Carreras I; Kowall NW; Jenkins BG; Dedeoglu A
    Exp Neurol; 2013 Dec; 250():228-238. PubMed ID: 24120437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cromolyn Reduces Levels of the Alzheimer's Disease-Associated Amyloid β-Protein by Promoting Microglial Phagocytosis.
    Zhang C; Griciuc A; Hudry E; Wan Y; Quinti L; Ward J; Forte AM; Shen X; Ran C; Elmaleh DR; Tanzi RE
    Sci Rep; 2018 Jan; 8(1):1144. PubMed ID: 29348604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic analysis of time-dependent neural effects of soluble amyloid β oligomers in culture and in vivo: Prevention by scyllo-inositol.
    Jin M; Selkoe DJ
    Neurobiol Dis; 2015 Oct; 82():152-163. PubMed ID: 26054438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A guanidine-appended scyllo-inositol derivative AAD-66 enhances brain delivery and ameliorates Alzheimer's phenotypes.
    Lee D; Lee WS; Lim S; Kim YK; Jung HY; Das S; Lee J; Luo W; Kim KT; Chung SK
    Sci Rep; 2017 Oct; 7(1):14125. PubMed ID: 29074878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robust amyloid clearance in a mouse model of Alzheimer's disease provides novel insights into the mechanism of amyloid-beta immunotherapy.
    Wang A; Das P; Switzer RC; Golde TE; Jankowsky JL
    J Neurosci; 2011 Mar; 31(11):4124-36. PubMed ID: 21411653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease.
    Brunner D; Flunkert S; Neddens J; Duller S; Scopes DIC; Treherne JM; Hutter-Paier B
    Neurosci Lett; 2017 Nov; 660():96-102. PubMed ID: 28917978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of increased scyllo-inositol in brain with magnetic resonance spectroscopy after dietary supplementation in Alzheimer's disease mouse models.
    Choi JK; Carreras I; Dedeoglu A; Jenkins BG
    Neuropharmacology; 2010; 59(4-5):353-7. PubMed ID: 20399219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focused ultrasound with anti-pGlu3 Aβ enhances efficacy in Alzheimer's disease-like mice via recruitment of peripheral immune cells.
    Sun T; Shi Q; Zhang Y; Power C; Hoesch C; Antonelli S; Schroeder MK; Caldarone BJ; Taudte N; Schenk M; Hettmann T; Schilling S; McDannold NJ; Lemere CA
    J Control Release; 2021 Aug; 336():443-456. PubMed ID: 34186148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically approved IVIg delivered to the hippocampus with focused ultrasound promotes neurogenesis in a model of Alzheimer's disease.
    Dubey S; Heinen S; Krantic S; McLaurin J; Branch DR; Hynynen K; Aubert I
    Proc Natl Acad Sci U S A; 2020 Dec; 117(51):32691-32700. PubMed ID: 33288687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The age-related slow increase in amyloid pathology in APP.V717I mice activates microglia, but does not alter hippocampal neurogenesis.
    Hoeijmakers L; Meerhoff GF; de Vries JW; Ruigrok SR; van Dam AM; van Leuven F; Korosi A; Lucassen PJ
    Neurobiol Aging; 2018 Jan; 61():112-123. PubMed ID: 29059594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.